Here’s what you should know:
1. Researchers believe hepatitis C is being spread by the opioid crisis.
2. They recommended all adults undergo a one-time universal screening to determine the impact of the disease.
3. Researchers used a computerized Markov state transition model to estimate the impact such a screening would have. They published the results in Clinical Gastroenterology and Hepatology.
4. Such a screening, followed by a guideline-based treatment, would create an incremental cost effectiveness ratio of $11,378 per quality-adjusted life year. University of Cincinnati’s Mark Eckman, MD, said, “Most health economists consider anything less than $50,000 per-quality adjusted life year to be highly cost-effective.”
More articles on gastroenterology:
The Joint Commission releases 4 ambulatory healthcare national patient safety goals for 2019
Going on the ‘cyberoffensive’: Tom Hui shares the 2 steps to take after a cybersecurity breach
Will Amazon shake up the ASC supply chain? Here’s what 4 experts say
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
